Karuna Therapeutics Inc.

NASDAQ: KRTX · Real-Time Price · USD
329.83
0.09 (0.03%)
At close: Mar 15, 2024, 9:00 PM

Karuna Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
185.82M 248.33M 206.95M
Short-Term Investments
1.08B 875.72M 287.04M
Long-Term Investments
n/a 261K 261K
Other Long-Term Assets
382K 690K 792K
Receivables
4.9M 57K 1.75M
Inventory
32.83M 28.32M 20.89M
Other Current Assets
14.77M 2.34M 708K
Total Current Assets
1.32B 1.15B 517.33M
Property-Plant & Equipment
20.51M 7.88M 9.54M
Goodwill & Intangibles
n/a -1.46M -1.92M
Total Long-Term Assets
20.9M 8.56M 10.34M
Total Assets
1.34B 1.16B 527.67M
Account Payables
6.78M 2.38M 1.94M
Deferred Revenue
41.61M n/a n/a
Short-Term Debt
2.84M 2.28M 2.17M
Other Current Liabilities
16.89M 29.29M 16.1M
Total Current Liabilities
68.13M 33.95M 20.21M
Long-Term Debt
13.85M 3.05M 5.33M
Other Long-Term Liabilities
n/a 104K 104K
Total Long-Term Liabilities
13.85M 3.15M 5.43M
Total Liabilities
81.97M 37.1M 25.64M
Total Debt
16.69M 5.33M 7.5M
Common Stock
4K 3K 3K
Retained Earnings
-997.89M -564.21M -287.87M
Comprehensive Income
211K -3.29M -497K
Shareholders Equity
1.25B 1.13B 502.03M
Total Investments
1.08B 875.72M 287.04M